Rett gene therapy NGN-401 selected for FDA’s START pilot program
The US Food and Drug Administration (FDA) has selected Neurogene’s NGN-401, an experimental gene therapy for Rett Syndrome, for the…
Fresh Content Everyday
The US Food and Drug Administration (FDA) has selected Neurogene’s NGN-401, an experimental gene therapy for Rett Syndrome, for the…
In any bioreactor, over time, only a certain percentage of cells actually produce what they were designed to express, says…
FISH HABITAT DEVELOPMENT – Approximately 9,000 2-inch TITAN MAXX Florida bass were released into Lake Monticello in early May to…
BY Stacy Jackson June 5, 2024 Data collected as part of the NIH-funded African Ancestry Breast Cancer Genetic consortium will…
Howard Chang, MD, PhD, professor of dermatology and genetics and the Virginia and DK Ludwig Professor in Cancer Research, has…
Researchers have identified Tmesipteris oblanceolataa fern from New Caledonia, as it has the largest genome on record, surpassing the previous…
In Hungary, ethological research is most often identified with tests on dogs, but new methodological advances may bring another species,…
Summary: A new gene therapy has restored hearing in both ears of five children with hereditary deafness, improving their hearing…